Diligence memo · auto-generated · as of July 2, 2026
TriAgenics, Inc
TriAgenics, Inc looks under-valued against its niche peers and is active on financing cadence.
Businessfiled
TriAgenics, Inc operates in Other Health Care, based in REDMOND.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
TriAgenics, Inc has raised $3.8M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.9M on 2020-12-15.
Most recent recorded round closed around 2025-04-11.
Valuation (modeled)modeled
Provath models TriAgenics, Inc at approximately $1.6M (range $423K–$3.4M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.37× the median modeled value of Seed Other Health Care companies in 2025–2027 (105 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 29 months.
Last raise 15 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
The last round was 3.8× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 59% of Other Health Care peers (5377 compared).
Modeled value ranks above 9% of those peers.
Closest niche peers: Xymogen, Inc., Willow Life Sciences, Inc., ManyClicks, Inc., Sterile State, Inc., Limber Prosthetics, Inc..
Peoplefiled
12 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.